NEW ENTERPRISE ASSOCIATES 15, L.P. / SENTI BIOSCIENCES, INC. -- SCHEDULE 13D

Company

Senti Biosciences, Inc.

Filed

July 15, 2022

Accession Number

0001072613-22-000487

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →